FdaApplication

ANDA 218261

Back to search

Identifiers

Properties

PropertyValue
applicant_nameLEADING PHARMA LLC
application_typeANDA
approval_date2025-03-03

Products (3)

ProductActive ingredientStrengthDosage form
OXAZEPAMOXAZEPAM10MGCAPSULE;ORAL
OXAZEPAMOXAZEPAM30MGCAPSULE;ORAL
OXAZEPAMOXAZEPAM15MGCAPSULE;ORAL

3 products